Table 3.
Optimal Cut Point |
Proportion Over Cut Point with ATN |
AUC (95% CI) | Validation AUC* |
|
---|---|---|---|---|
Tubular injury markers | ||||
NGAL (ng/ml) | 365 | 25/35 (71%) | 0.78 (0.69–0.88) | 0.787 |
IL-18 (pg/ml) | 85 | 21/33 (64%) | 0.71 (0.61–0.81) | 0.711 |
KIM-1 (ng/ml) | 15.4 | 15/24 (63%) | 0.64 (0.53–0.75) | 0.639 |
L-FABP (ng/ml) | 25 | 21/30 (70%) | 0.69 (0.57–0.80) | 0.688 |
Tubular function marker | ||||
FENa (%) | 0.1 | 22/62 (35%) | 0.56 (0.45–0.68) | 0.563 |
Glomerular injury marker | ||||
Albumin (mg/dL) | 44 | 29/52 (56%) | 0.73 (0.64–0.83) | 0.734 |
Abbreviations: ATN, acute tubular necrosis; AUC, area under the curve; CI, confidence interval; NGAL, neutrophil gelatinase associated lipocalin; IL-18, interleukin-18; KIM-1, kidney injury molecule-1; L-FABP, liver-type fatty acid binding protein; FENa, fractional excretion of sodium
Validation AUCs derived from leave-10-out cross validation performed with SAS Proc Surveyselect